10:36 AM EDT, 10/22/2024 (MT Newswires) -- NeoGenomics ( NEO ) said Tuesday that the New York State Department of Health granted conditional approval for the company's Neo Comprehensive Solid Tumor assay and NeoType DNA & RNA Lung tests.
The approval allows for commercial access in New York, the provider of oncology testing services said.
NeoGenomics ( NEO ) shares were up 0.7% in recent trading.
Price: 13.22, Change: +0.09, Percent Change: +0.69